ãã¡ãŠãå NIAIDæé·ã¯ãã³ãããã¯ã仿ããã°ã«ãŒãã®æã人圢
ããã§ã«äžçã®å€ãã«äººã¯ãCOVID-19ïŒ2019幎-ã³ãããŠã€ã«ã¹ææçïŒã¯ã¯ãã³ããæåŠããŠããããã ãããã®åé¡ã¯çµãã£ãŠããªããçµãããªããŸãŸé èœå·¥äœãé²ãã§ãããCOVID-19éšåã®è±¡åŸŽçãªäººç©ã§ããã¢ã³ãœããŒã»ãã¡ãŠãã¯1984幎11æãã2022幎12æãŸã§NIAIDïŒåœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒã®æé·ãåããããéšåã®é»å¹ãšã¯èšããªããé»å¹ã¯ãã¡ãŠãã«è²¬ä»»ãæŒãä»ããéããããšããŠããããã«èŠããã
ããã®ãCOVID-19ã¯ã¯ãã³ãã¯äººéã®çްèãžLNPïŒè質ããç²åïŒã«å ãŸããmRNAãéã蟌ã¿ããŠã€ã«ã¹ã®ã¹ãã€ã¯ã»ã¿ã³ãã¯ãäœãããã®ã ãã人éã®å ç«ã·ã¹ãã ã¯ã¹ãã€ã¯ã»ã¿ã³ãã¯ãç åäœã ãšå€æãæ»æãããããèªå·±å ç«çŸæ£ãåŒãèµ·ããã
ãããã§ãCOVID-19ã¯ã¯ãã³ãã«ã¯å ç«ãäžããä»çµã¿ãçµã¿èŸŒãŸããŠããã®ã ããããã ãã§ãªãå ç«æå¶èœåãããIgG4æäœãèªå°ããããã€ãŸãAIDSç¶æ ã«ãªããéåžžãªãåé¡ã®ãªã埮çç©ã§ãç æ°ã«ãªããçãå¢ããã
ããŸããLNPã¯äººäœã«æå®³ã§ãããDNAãã°ã©ãã§ã³èªå°äœã®æ··å ¥ãå ±åãããŠãããçºçæ§ã®ããDNAãŠã€ã«ã¹ãSV40ãæ··å ¥ããŠããããšãçºèŠãããããã¡ã€ã¶ãŒç€Ÿã®mRNA補å€ãå€ãã®ãéºäŒåç·šéãã«ã¯ãã«ã®äžã«å ¥ã£ãŠããã®ã ããéºäŒåæ²»çã«äœ¿ãããSV40ã¯åæååŠç©è³ªã ãšãããSV40ããã®æ§æèŠçŽ ãæå³çã«åæããéºäŒåæ²»çã®äž»èŠæåãšããŠçµã¿èŸŒãããšã¯èš±ãããŠããã
ããã®COVID-19éšåã¯2019幎12æã®çµããã«äžåœã®æŠæŒ¢ã®ç é¢ã§èºçæ£è 9åã»ã©ãèŠã€ãã£ããšããããå§ãŸããç¿å¹Žã®2æ4æ¥ãæšªæµæž¯ããåºæž¯ããããšããŠããã¯ã«ãŒãºè¹ããã€ã€ã¢ã³ãã»ããªã³ã»ã¹ãã§æ£è ãçºèŠããã3æ11æ¥ã«WHOïŒäžçä¿å¥æ©é¢ïŒããã³ãããã¯å®£èšããéçã®èºçæ£è ãè¡ã«ããµããæ»è ãæ¥å¢ããããšããã€ã¡ãŒãžãäœããã人ã³ãšãææããæµããšã«ãªã£ãã
ãå¥ã®ã¯ã«ãŒãºè¹ãã°ã©ã³ãã»ããªã³ã»ã¹ãã§ãæ£è ãçºèŠããã3000人以äžãææããããææããã人ã³ãšã¯ãç¡çç¶ã®èŽæ»æ§çŸæ£ããªã話ãå¹ã蟌ãŸãã蚎远ã®è è¿«ãåããã¢ã¡ãªã«ç©ºè»ã®åºå°ã«ããè»äºååæïŒéé¢ãã£ã³ãïŒã«å容ããããšããã
ãããããWHOããã³ãããã¯å®£èšããçŽåã®2020幎2æ28æ¥ããã¡ãŠããå«ã3åã®ç ç©¶è ã¯COVID-19ã®èŽæ»çã1ïŒ æªæºãããããªããšçºè¡šããŠãããã€ãŸãå£ç¯æ§ã€ã³ãã«ãšã³ã¶äžŠã¿ã ãšããã®ã ãåœåããã¡ãŠãã¯COVID-19éšåã仿ããåŽã§ã¯ãªãã£ãããã®åŸãéšåãç œãåŽã«å ¥ã£ãã®ã ã
ãæ·±å»ãªå¯äœçšãåŒãèµ·ãããCOVID-19ã¯ã¯ãã³ããéçºãããã¡ã€ã¶ãŒç€Ÿã®é¢é£ææžãFDAïŒé£åå»è¬åå±ïŒã¯75幎ã®éå°å°ããããšããã®ã ããã¢ã¡ãªã«ã§ã¯äžéšã®å°éå®¶ã¯æ å ±ã®éç€ºãæ±ãã蚎èšãèµ·ãããè¿ éãªå ¬éãåœä»€ãããã
ãé·å¹Žãå»è¬åæ¥çã§ç ç©¶éçºã«æºãã£ãŠãããµãŒã·ã£ã»ã©ãã£ãã¯ã¯å ¬éãããææžãåæããã®çµæããCOVID-19ã¯ã¯ãã³ãã¯ã¢ã¡ãªã«åœé²ç·çã®ãããžã§ã¯ãã ãš2022幎ã«çºè¡šãããã€ãŸãéšåã¯è»äºäœæŠã®çµæã§ãããå»è¬åã¡ãŒã«ãŒã¯åœé²ç·çã®å¥çŽäŒæ¥ãšããããšãããããäŒæ¥ã¯æ å ±ãå ¬éããå¿ èŠããªããåœé²ç·çã®ãããžã§ã¯ãã ãšããããšã¯è»äºäœæŠã ãšããããšãæå³ããè»äºäœæŠã¯å 責ã ã
ãç åäœã ãšãããSARS-CoV-2ïŒéçæ¥æ§åŒåžåšçå矀ã³ãããŠã€ã«ã¹2ïŒã¯æŠæŒ¢ã®ç ç©¶æã§äœããããšãã話ãåºãŸã£ãŠãããããã®ãŠã€ã«ã¹ã«ææããåç©ã¯äžåœã§ãªããåã¢ã¡ãªã«ã§èŠã€ãã£ãŠããããžã ã»ãã¹ã©ã ã«ãããšãåã¢ã¡ãªã«ã®èªç¶çã§ã¯ã·ã«ããããºããã³ãŠã¢ãªãå«ã5çš®é¡ã®åç©ãææããŠããããšã倿ããããã®çš®ã¯ã¢ã³ã¿ãå·ã«ããããããŒã»ããŠã³ãã³ç ç©¶æã§å®éšåç©ãšããŠäœ¿çšãããŠããããšãçªãæ¢ãããããïŒJim Haslam, âCOVID-19 Mystery Solved,â Truth Seeking Press, 2024ïŒ
ãCOVID-19éšåãç œãããã«WHOã¯ãã³ãããã¯ã宣èšãããããã®ããã«æ»äº¡è æ°ãæ°Žå¢ãããå¿ èŠããã£ããããã§WHOãCDCïŒçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒã¯2020幎4æãæ»äº¡ããæ£è ã®çç¶ãCOVID-19ã«ãããã®ã ãšèããŠççŸããªããªãæ»å ãCOVID-19ãšããŠåŠçããŠè¯ããšããééãåºããŠãããã€ãŸãæ£è ãæ°Žå¢ãããããã«æç€ºããŠããã®ã ã
ãã¢ã¡ãªã«äžé¢ã®ã¹ã³ããã»ãžã£ã³ã»ã³è°å¡ã¯2020幎4æ8æ¥ããã®ééã«ã€ããŠFOXãã¥ãŒã¹ã®çªçµã§è©±ããŠãããç é¢ã¯æ»äººãåºããšæ€æ»ãããªããŸãŸæ»äº¡èšºææžã«COVID-19ãšæžã蟌ãã§ãããšè©±ããŠããã®ã ãã¢ã¡ãªã«ã®å ŽåãCOVID-19ã«ææããŠããæ£è ãæ²»çãããšç é¢ãåãåããéé¡ãå€ããªãã人工åŒåžåšãã€ãããšãã®é¡ã¯3åã«èšããã ãšããããå»çé¢ä¿è ãè²·åãããšèšãããŠã仿¹ããªãã
ããã³ãããã¯å®£èšãæ£åœåãããããPCRïŒããªã¡ã©ãŒãŒé£éåå¿ïŒæ€æ»ãå©çšããããããã¯ç¹å®ã®éºäŒååã詊éšç®¡ã®äžã§å¢å¹ ããåæã®ããã®æè¡ã ããå¢å¹ ã§ããéºäŒåã®é·ãã¯ãŠã€ã«ã¹å šäœã®æ°çŸåã®1çšåºŠã«ãããããŠã€ã«ã¹èªäœãèŠã€ããããšã¯ã§ããªãã
ãå¢å¹ ã®åæ°ïŒCtå€ïŒãå¢ãããŠããã°å»åŠçã«æå³ã®ãªãã»ã©åŸ®éã®éºäŒåãååšããŠãéœæ§ã«ãªããåœéœæ§ãå¢ãããåœéœæ§ãæé€ããããã«ã¯Ctå€ã17以äžã«ããªããã°ãªããã35ãè¶ ããšåœéœæ§ã®æ¯çã¯97ïŒ ã«ãªããšãå ±åãããŠãããã¡ãªã¿ã«ã2020幎3æ19æ¥ã«åœç«ææçç ç©¶æãåºãããç åäœæ€åºããã¥ã¢ã«ãã®Ctå€ã¯40ã ã
ãCtå€ãããããæ°å€ã«èšå®ãããªãPCRæ€æ»ã¯ç¡æå³ã ããçµæã ãã¯åºãã®ã§äººã³ãšãéšãææã«ã¯äœ¿ãããPCRãéçºã1993幎ã«ããŒãã«ååŠè³ãåè³ãããã£ãªãŒã»ããªã¹ãPCRã蚺æã«äœ¿ã£ãŠã¯ãªããªããšèªã£ãŠããã
ãããããå±éºãªè¬ç©ãæ¥æ¬æ¿åºã¯åœæ°ã«æ¥çš®ããããããå€§èŠæš¡ãªå®£äŒãå±éããããéåžžã®åœã¯å±éºæ§ã«æ°ã¥ãã2åçšåºŠã§æ¢ãæããã®ã ããæ¥æ¬ã¯äœåºŠãæ¥çš®ããããæ¥çš®æšé²ã®ããã«ãã¹ã³ããæããã圹å²ã¯éãã
ããã®è¬ç©ã«ãã£ãŠå°ãªããã¬ç ç²è ãåºãŠããã®ã¯ééããªãããã®çç±ãå»è¬åã¡ãŒã«ãŒã®åŒ·æ¬²ãã«æ±ãããã¡ãŠãã®ãããªäººç©ã«è²¬ä»»ãæŒãä»ããæèŠããããããã®èåŸã«ã¯ã¢ã¡ãªã«ã®åœé²ç·çãååšããŠãããã€ãŸãCOVID-19éšåã¯ã¢ã¡ãªã«åœé²ç·çã®è»äºäœæŠã§ãããå»è¬åã¡ãŒã«ãŒã¯ãåœå®¶å®å šä¿éããšããå£ã«å®ãããŠããã
ããµãŒã·ã£ã»ã©ãã£ãã¯ãæ©ã段éããææããŠããããã«ãCOVID-19éšåã¯åœé²ç·çã®ãããžã§ã¯ãã ãåœŒå¥³ã¯æ å ±å ¬éæ³ã«ãã£ãŠå ¥æããææžãåæããã®çµè«ã«è³ã£ãã
ãåœé²ç·çã®DARPAã¯2001幎9æ11æ¥ã®åŸã«ã¯ã¯ãã³éçºã®ä¿é²ãæ°ãŠã€ã«ã¹ã®çºèŠãå»è¬å補é ã®è¿ éåãªã©ã®æè¡ãéçºããããã«æè³ããããã«ãªã£ããããããäžã空è»ã®ãã³ã»ã¯ããã³ãã«ããè¿ éãªãã³ãããã¯å¯Ÿå¿ãDARPAã®åªå äºé ã®ãããã«æŒãäžãããšããã
ãã¯ããã³ãã«ãã¯DARPAã§ããã°ã©ã ã»ãããŒãžã£ãŒãåãã蚺æåŠãåºä¹³é¡çްèåæçç©åŠãRNAã¯ã¯ãã³ãã¢ãã¯ããŒãã«æäœã®è¿ éãªçºèŠãéºäŒåå°å ¥ã«ããå ç«äºé²ã人工赀è¡çãªã©ã®ããã°ã©ã ãç«ã¡äžãããšãããDARPAã¯2013幎ã«ã¢ãã«ããžæé«2500äžãã«ã婿éãšããŠæäŸããããšã«æ±ºãã16幎ã«ã¯ããã³ãã«ãã¯ãã«ã»ã¢ã³ãã»ã¡ãªã³ãã»ã²ã€ã財å£ãžç§»ç±ããã
ã2005幎8æã«åœé²ç·çã¯ãŠã¯ã©ã€ãæ¿åºãšå¥çŽãçµã³ãååœã«ããçç©ç ç©¶æœèšãã¢ã¡ãªã«æ¿åºã管çããããšã«ãªãããããŠã¢ã¡ãªã«ã¯ãŠã¯ã©ã€ãã§çç©ååŠå µåšã®ç ç©¶éçºãéå§ããã
ãCOVID-19éšåãè»äºäœæŠã ãšããŠããåœé²ç·çãšå¥çŽããŠããå»è¬åäŒç€Ÿã«ãšã£ãŠã¯ããžãã¹ã§ããããªãã¢ã®æå°è ã ã£ãã ã¢ã³ãã«ã»ã¢ã«ã»ã«ããã£ã¯2009幎ãåœé£ã§æ¬¡ã®ããã«æŒèª¬ããããå°æ¥ãå€ãã®ãŠã€ã«ã¹ãçºçããã ãããäŒæ¥ã¯ããããéçºããããã«æžåœã«åãçµãã§ãããããŠã€ã«ã¹ãäžçã«èå»¶ããã°ããã¯ã¯ãã³æ¥çš®ã§è«å€§ãªå©çãåŸãããšãã§ããããšããããã ããããŠãã¯ã¯ãã³ãç¡æã«ãªãã°ãããããæªç¥ã®ãŠã€ã«ã¹ã®å€ãã¯åºçŸãèå»¶ãããªããªãã ããããšã«ããã£ã¯äºæž¬ããŠããã

**********************************************